Tris Pharma, Inc.
Clinical trials sponsored by Tris Pharma, Inc., explained in plain language.
-
New pain drug shows promise for tummy tuck recovery
Symptom relief CompletedThis study tested a new pain medicine called cebranopadol for people with moderate to severe pain after a tummy tuck (abdominoplasty). About 279 adults took part, and some received the drug while others got a placebo. The goal was to see if the drug safely reduces pain over the f…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated May 17, 2026 07:32 UTC
-
New pain drug shows promise for Post-Surgery relief
Symptom relief CompletedThis study tested a new pain medication called cebranopadol in 240 adults who had bunion surgery. The goal was to see if it safely reduces moderate to severe acute pain better than a placebo or an active comparator. Participants were randomly assigned to receive the drug, a place…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC
-
New opioid-like drug tested for abuse risk in recreational users
Knowledge-focused CompletedThis study looked at how likely a new painkiller called cebranopadol is to be abused compared to oxycodone and a placebo. It involved 48 healthy adults who had used opioids for fun in the past. Participants received each drug through the nose and rated how much they liked it, to …
Phase: PHASE1 • Sponsor: Tris Pharma, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 07:34 UTC